Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to stock its...
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to develop and commercialise up...
Vir biotech has managed to drum up $500 million in financing, acquire a company and strike agreements with two companies to develop clinical and...
Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one of the regulators advisory...
Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA's approval for the CAR-T therapy, Yescarta,...
It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be broken down into two areas: in the...
Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a national emergency, two months...
It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product...
Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches